26. HTLV-1関連脊髄症 HTLV-1-associated myelopathy Clinical trials / Disease details
臨床試験数 : 28 / 薬物数 : 48 - (DrugBank : 28) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 127
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02961712 (ClinicalTrials.gov) | July 2016 | 3/11/2016 | Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM) | Immunotherapy of Natural Killer in HTLV-1 Associated Myelopathy | HAM | Biological: NK cells;Biological: amniotic epithelial cells | The Second Affiliated Hospital of Fujian Medical University | Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China | Recruiting | 18 Years | 75 Years | All | 15 | Phase 1 | China |